Trials / Completed
CompletedNCT00481273
AVIDA The Vidaza® (Azacitidine) Patient Registry
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 479 (actual)
- Sponsor
- Celgene · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This registry is a prospective, multi-center, observational study compiling data on the natural history and management of patients receiving Vidaza, and will provide unique insights into the management of myelodysplastic syndromes (MDS) and other hematological disorders and the impact of these disorders on patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azacitidine | Physician's discretion |
Timeline
- Start date
- 2006-10-31
- Primary completion
- 2010-08-31
- Completion
- 2010-08-31
- First posted
- 2007-06-01
- Last updated
- 2018-05-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00481273. Inclusion in this directory is not an endorsement.